Detalhe da pesquisa
1.
Immunomodulatory activity of trifluoromethyl arylamides derived from the SRPK inhibitor SRPIN340 and their potential use as vaccine adjuvant.
Life Sci
; 307: 120849, 2022 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35926588
2.
The SRPK inhibitor N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl) isonicotinamide (SRPIN340) increases the immune response against metastatic melanoma in mice.
Biochem Pharmacol
; 203: 115161, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35787994